IS4436A - Antiviral nucleoside analogues containing substituted benzimidazole bases linked to a carbon ring - Google Patents

Antiviral nucleoside analogues containing substituted benzimidazole bases linked to a carbon ring

Info

Publication number
IS4436A
IS4436A IS4436A IS4436A IS4436A IS 4436 A IS4436 A IS 4436A IS 4436 A IS4436 A IS 4436A IS 4436 A IS4436 A IS 4436A IS 4436 A IS4436 A IS 4436A
Authority
IS
Iceland
Prior art keywords
carbon ring
nucleoside analogues
containing substituted
substituted benzimidazole
antiviral nucleoside
Prior art date
Application number
IS4436A
Other languages
Icelandic (is)
Inventor
B. Townsend Leroy
Mary Daluge Susan
Original Assignee
The Wellcome Foundation Limited
The Regents Of The University Of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/304,006 external-priority patent/US5534535A/en
Application filed by The Wellcome Foundation Limited, The Regents Of The University Of Michigan filed Critical The Wellcome Foundation Limited
Publication of IS4436A publication Critical patent/IS4436A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
IS4436A 1994-09-09 1997-03-07 Antiviral nucleoside analogues containing substituted benzimidazole bases linked to a carbon ring IS4436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/304,006 US5534535A (en) 1992-03-09 1994-09-09 Therapeutic nucleosides
PCT/US1995/011366 WO1996007646A1 (en) 1994-09-09 1995-09-11 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring

Publications (1)

Publication Number Publication Date
IS4436A true IS4436A (en) 1997-03-07

Family

ID=23174626

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4436A IS4436A (en) 1994-09-09 1997-03-07 Antiviral nucleoside analogues containing substituted benzimidazole bases linked to a carbon ring

Country Status (17)

Country Link
EP (1) EP0779885A1 (en)
JP (1) JPH10505092A (en)
CN (1) CN1164855A (en)
AP (1) AP741A (en)
AU (1) AU3692895A (en)
BR (1) BR9508826A (en)
CA (1) CA2199502A1 (en)
CZ (1) CZ71297A3 (en)
FI (1) FI970959A (en)
HU (1) HUT77440A (en)
IS (1) IS4436A (en)
NO (1) NO971070L (en)
NZ (1) NZ294095A (en)
OA (1) OA10601A (en)
PL (1) PL319440A1 (en)
SK (1) SK29197A3 (en)
WO (1) WO1996007646A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912356A (en) * 1995-09-11 1999-06-15 Glaxo Wellcome Inc. Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
WO1998035977A1 (en) 1997-02-13 1998-08-20 Glaxo Group Limited Benzimidazole derivatives
PL338454A1 (en) 1997-07-30 2000-11-06 Univ Michigan Lixofuranosilbenzimidazoles as antiviral agents
ID30204A (en) 1999-12-27 2001-11-15 Japan Tobacco Inc COMPOUNDS OF DIFFUSED RING AND ITS USE AS A MEDICINE
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AR035543A1 (en) * 2001-06-26 2004-06-16 Japan Tobacco Inc THERAPEUTIC AGENT FOR HEPATITIS C THAT INCLUDES A CONDENSED RING COMPOUND, CONDENSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS, BENZIMIDAZOL, THIAZOL AND BIFENYL COMPOUNDS USED AS INTERMEDIARY COMPARTMENTS OF COMPARTMENTS
CN1834090B (en) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 Benzimidazole compounds, its preparation and uses
ES2655028T3 (en) 2007-08-02 2018-02-16 Millennium Pharmaceuticals, Inc. Process for the synthesis of E1 activation enzyme inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
CN1164855A (en) 1997-11-12
PL319440A1 (en) 1997-08-04
FI970959A0 (en) 1997-03-06
AP9700940A0 (en) 1997-04-30
SK29197A3 (en) 1997-10-08
NO971070L (en) 1997-05-07
AU3692895A (en) 1996-03-27
AP741A (en) 1999-04-26
MX9701789A (en) 1997-10-31
CZ71297A3 (en) 1997-08-13
FI970959A (en) 1997-05-06
NZ294095A (en) 1998-08-26
WO1996007646A1 (en) 1996-03-14
CA2199502A1 (en) 1996-03-14
JPH10505092A (en) 1998-05-19
OA10601A (en) 2002-09-03
HUT77440A (en) 1998-04-28
BR9508826A (en) 1997-09-30
EP0779885A1 (en) 1997-06-25
NO971070D0 (en) 1997-03-07

Similar Documents

Publication Publication Date Title
NO940322L (en) 1,3-oxathiolane nucleoside analogues
ZA913293B (en) 1,3-oxathiolane nucleoside analogues
MY102693A (en) Antiviral nucleosides
ATE231874T1 (en) ANTIVIRAL PURINE DERIVATIVES
ZA918685B (en) Polysubstituted benzimidazoles as antiviral agents
DK23489D0 (en) nucleoside
IS4436A (en) Antiviral nucleoside analogues containing substituted benzimidazole bases linked to a carbon ring
NO20006631D0 (en) Compounds obtained from sage species with antiviral activity
DE3752037T2 (en) Glass-like carbon composite
IL125447A0 (en) Modified benzimidazole nucleosides as antiviral agents
DE69127010T2 (en) Selective adenosine receptors
DK1140937T3 (en) Antiviral nucleoside analogues
IT8548949A0 (en) PROCEDURE FOR THE POST-PURIFICATION OF HYDROGEN CHLORIDE FROM A PYROLYSIS OF I,2-DICHLOROETHANE
DE68914750T2 (en) Therapeutic nucleosides.
IT8667760A0 (en) IMPROVED TYPE DISSIPATIVE SILENCER
GB9111967D0 (en) 2,5'-nucleotide analogs as antiviral agents
HRP940041A2 (en) 1,3-oxathiolane nucleoside analogues
KR870019334U (en) Headphone microphone bar fixture
ES292614Y (en) SURVIVAL VEST
DK641987A (en) SURVIVAL ACTIVITIES
ATE104675T1 (en) THERAPEUTIC NUCLEOSIDES.
KR880021885U (en) Hydrogen gas generator
IT1220402B (en) HANDLEBAR ATTACHMENT, PARTICULARLY FOR BICYCLES